Another report indicated that the expression level of PPARG in FLSs of RA patients was significantly reduced compared with healthy FLSs [30]; this implies that the activation of the PPAR signaling pathway might be a therapeutic mechanism against RA. Here, PPARG is linked to rheumatoid arthritis.